Abstract
For a group of individuals, population pharmacokinetic studies describe the interindividual variability through a statistical distribution. These studies conducted during the drug development serve as a useful marker of the safety of the drug, provide information that might be decisive for future experiments and, in a clinical context, help establish guidelines for optimal use in each patient.
As complementary tools to the existing statistical and graphical techniques for population pharmacokinetic data analysis, indexes derived from information theory were used to select the most appropriate model for the statistical distribution, to detect atypical individuals, and to screen influential covariates. The rationale for using these indexes is shown using simulated and real data.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
L. B. Sheiner. The population approach to pharmacokinetic data analysis: Rationale and standard data analysis methods. Drug Metab. Reû . 15:153–171 (1984).
H. Fhüler, H. Huber, E. Widmer, and S. Brechbüler. Experiences in the application of NONMEM to pharmacokinetic data analysis. Drug Metab. Reυ. 15:317–339 (1984).
J. L. Steimer, S. Vozeh, A. Racine-Poon, N. H. G. Holford, and R. O'Neil. The population approach: Rationale, methods, applications in clinical pharmacology and drug development. In P. G. Welling and L. P. Balant, (eds.), Pharmacokinetics of Drugs, Handbook of Experimental Pharmacology Springer, Verlag, Berlin, 1994, pp. 405–451.
T. H. Grasela and L. B. Sheiner. Pharmacostatistical modeling for observational data. J. Pharmacokin. Biopharm. 19:25–36 (1991).
A. Iliadis. Information tools used in population pharmacokinetics. In J. M. Aiache (ed.), 6th European Congress of Biopharmaceutics and Pharmacokinetics, Athens, Médecine et Hygiéne, 1996, pp. 143.
E. I. Ette and T. M. Ludden. Population pharmacokinetic modeling: The importance of informative graphics. Pharm. Res. 12:1845–1855 (1995).
S. Kapur. Maximum Entropy Models in Science and Engineering. John Wiley, New York, 1989.
D. V. Lindley. On a measure of the information provided by an experiment. Ann. Math. Stat. 27:986–1005 (1956).
M. Stone. Application of a measure of information to the design and comparison of regression experiments. Ann. Math. Stat. 30:55–70 (1959).
M. C. Jones and R. Sibson. What is projection pursuit? (with discussion). J. Roy. Stat. Soc. 150:1–36 (1987).
Y. Bard. Nonlinear Parameter Estimation. Academic Press, New York, 1974.
S. J. Press. Applied Multiυariate Analysis. Holt, Rinehart, and Winston, New York, 1972.
D. W. Scott. Multiυariate Density Estimation. Theory, Practice, and Visualization. John Wiley, New York 1992.
B. W. Silverman. Density Estimation for Statistics and Data Analysis. Chapman and Hall, London 1992.
H. Akaike. A new look at the statistical model identification. IEEE T. Automat. Contr. 19:716–723 (1974).
H. Akaike. On entropy maximization principle. In P. R. Krishnaiah (ed.), Applications of Statistics, North Holland, Amsterdam, 1977, pp. 27–41.
V. Barnett and T. Lewis. Outliers in Statistical Data. John Wiley, New York 1994.
S-PLUS. Guide to Statistics. 4.5 ed. MathSoft, Inc., Seattle WA, 1998.
J. P. Richard. Entropy. In D. P. Atherton and P. Borne (eds.), Concise Encyclopedia of Modelling and Simulation, Pergamon Press, Oxford, 1992, pp. 104–105.
H. Joe. Relative entropy measures of multivariate dependence. J. Am. Stat. Assoc. 84:157–164 (1989).
C. Puozzo, C. Filaquier, and M. Briley. Plasma levels of F2207, milnacipran, a novel antidepressant, after single oral administration in volunteers. Br. J. Clin. Pharm. 20:291–292 (1985).
A. Stenger, J. P. Cousinier, and M. Briley. Psychopharmacology of milnacipran, 1-phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane hydrochloride (F2207), a new potential antidepressant. Psychopharmacology 91:147–153 (1987).
J. P. Macher, J. P. Sichel, C. Serre, R. von Frenckell, J. C. Huck, and J. P. Demarez. Double blind placebo controlled study of milnacipran in hospitalized patients with major depressive disorders. Neuropsychobiology 22:77–82 (1990).
A. Iliadis, A. C. Brown, and M. L. Huggins. APIS: A software for identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics. Comput. Meth. Prog. Biomed. 38:227–239 (1992).
L. Claret and A. Iliadis. Nonparametric density estimation applied to population pharmacokinetics. Math. Biosci. 133:51–68 (1996).
MATLAB. High-performance Numeric Computation and Visualization Software. 5.2 ed. The MathWorks, Natick MA, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Petricoul, O., Claret, L., Barbolosi, D. et al. Information Tools for Exploratory Data Analysis in Population Pharmacokinetics. J Pharmacokinet Pharmacodyn 28, 577–599 (2001). https://doi.org/10.1023/A:1014464505261
Issue Date:
DOI: https://doi.org/10.1023/A:1014464505261